Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 trends tracked about this subject — the full history, oldest to newest below.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
14 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Moderna and Merck trial data sparks debate over whether a personalized medicine revolution is beginning.
BioNTech and Genentech have terminated a phase 2 mRNA colorectal cancer vaccine trial after safety reviews revealed more deaths than in the control group.
Analysts are closely monitoring the impact of intismeran following a landmark Phase III clinical trial victory in the cancer vaccine sector.
Moderna and Merck have reported a significant triumph regarding a collaborative cancer vaccine trial that could revolutionize oncology treatment.
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Moderna and Merck report success in a late-stage melanoma trial for their personalized mRNA cancer vaccine.
Scientific testing is currently underway on new vaccines designed to intercept hereditary colon and pancreatic cancers.